Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A sensitive specific hemolytic assay for proenzyme C1.

A J Tenner, M M Frank

    Complement (Basel, Switzerland)
    |January 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    CD200 modulates macrophage cytokine secretion and phagocytosis in response to poly(lactic co-glycolic acid) microparticles and films.

    Journal of materials chemistry. B·2017
    Same author

    Complement activation.

    Immunology today·2014
    Same author

    Synthesis and release of sucrose by the aleurone layer of barley: Regulation by gibberellic acid.

    Planta·2014
    Same author

    Wild-type adenoviruses from groups A-F evoke unique innate immune responses, of which HAd3 and SAd23 are partially complement dependent.

    Gene therapy·2008
    Same author

    Directing an appropriate immune response: the role of defense collagens and other soluble pattern recognition molecules.

    Current drug targets·2008
    Same author

    Recombinant adenovirus vectors activate the alternative complement pathway, leading to the binding of human complement protein C3 independent of anti-ad antibodies.

    Molecular therapy : the journal of the American Society of Gene Therapy·2004
    Same journal

    Patients with CLL and hypocomplementaemia have an impaired serum bactericidal activity against the Salmonella minnesota Re mutant.

    Complement (Basel, Switzerland)·1988
    Same journal

    Structure of C3f, a small peptide specifically released during inactivation of the third component of complement.

    Complement (Basel, Switzerland)·1988
    Same journal

    Effects of anti-C4 antibody on complement production by splenic and peritoneal macrophages.

    Complement (Basel, Switzerland)·1988
    Same journal

    C4-binding protein prevents spontaneous cleavage of C3 in sera of patients with hereditary angioedema.

    Complement (Basel, Switzerland)·1988
    Same journal

    Inhibition of C1q functions by RHP, a protein elevated in sera from patients with rheumatoid arthritis.

    Complement (Basel, Switzerland)·1988
    Same journal

    2nd European Meeting on Complement in Human Disease. September 19-22, 1988, Bari, Italy. Abstracts.

    Complement (Basel, Switzerland)·1988
    See all related articles

    A new two-step assay differentiates between unactivated (proenzyme) C1 and activated C1. This method quantifies both forms of C1, improving understanding of the classical complement pathway and C1 function.

    Area of Science:

    • Immunology
    • Biochemistry

    Background:

    • The classical complement pathway is initiated by the C1 complex.
    • Differentiating between proenzyme C1 and activated C1 is crucial for understanding complement function.
    • Traditional hemolytic assays lack the specificity to distinguish these two states.

    Purpose of the Study:

    • To develop a modified hemolytic assay for differentiating and quantifying proenzyme C1 and activated C1.
    • To establish a method for assessing the functional states of C1 in biological samples.

    Main Methods:

    • A two-step hemolytic assay involving preincubation with C1 inhibitor.
    • Utilizing C1 inhibitor to specifically block enzymatic activity of activated C1.
    • Quantifying proenzyme C1 by measuring residual hemolytic activity after C1 inhibitor treatment.

    Related Experiment Videos

    Main Results:

    • The assay successfully differentiates between proenzyme C1 and activated C1.
    • Both absolute and relative amounts of proenzyme and activated C1 can be quantified.
    • A partially purified C1 inhibitor reagent demonstrated efficacy, simplifying its preparation.
    • Evidence for temperature- and concentration-dependent steps in functional C1 formation was found.

    Conclusions:

    • The developed assay provides a sensitive and specific method for assessing C1 functional states.
    • This assay facilitates research into complement pathway regulation and disorders.
    • The findings contribute to understanding the assembly and activation dynamics of the C1 complex.